Tom Marino Withdraws From Drug Czar Consideration

Trump pulls back nomination after scrutiny into Marino’s ties to drug distributors.

Rep. Tom Marino (R-Pa.)Bill Clark/Roll Call/AP

President Trump announced on Tuesday morning that Rep. Tom Marino (R-Pa.), who had been nominated to be the nation’s drug czar, is withdrawing his name from consideration. The news comes days after reports that Marino co-sponsored legislation that weakened the Drug Enforcement Administration’s ability to crack down on drug distributors that helped fuel the opioid epidemic. 

Several members of congress called for Marino’s withdrawal after an investigation published Sunday by the Washington Post and “60 Minutes” detailed Marino’s involvement in steering the legislation, entitled the Ensuring Patient Access and Effective Drug Enforcement Act. Mother Jones also detailed his role in spearheading the legislation, as well as his substantial campaign contributions from drug distributors, last week

Trump announced Monday that he would declare the opioid epidemic to be a national emergency—something he’s promised to do since August.  “We are going to be doing that next week,” he said in an impromptu Rose Garden press conference on Monday. “To get to that step, a lot of work has to be done, and it’s time-consuming work. We’re going to be doing it next week.”

Asked at the same press conference about the media reports on Marino, Trump said, “We’re going to be looking into Tom.”

Fact:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn’t fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation so we can keep on doing the type of journalism that 2018 demands.

Donate Now
  • Julia Lurie

    Julia Lurie is a reporter at Mother Jones. You can reach her at jlurie@motherjones.com.